Saskia M. Cillessen

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Evaluation of homologous recombination testing in ovarian carcinoma.

Evaluation of homologous recombination testing in ovarian carcinoma.

Journal: Virchows Archiv : an international journal of pathology

Published: November 27, 2025

Correct diagnosis of patients with fibrolamellar carcinoma: A Dutch nationwide study.

Correct diagnosis of patients with fibrolamellar carcinoma: A Dutch nationwide study.

Journal: Histopathology

Published: May 28, 2025

Aberrant intra-epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103-β7-receptor-mediated granzyme-B degranulation which can be restored by etrolizumab.

Aberrant intra-epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103-β7-receptor-mediated granzyme-B degranulation which can be restored by etrolizumab.

Journal: Clinical & translational immunology

Published: May 27, 2025

Improving cell-free DNA detection in advanced-stage high-grade serous ovarian cancer using combined TP53 mutational status and copy number changes.

Improving cell-free DNA detection in advanced-stage high-grade serous ovarian cancer using combined TP53 mutational status and copy number changes.

Journal: Pathology, research and practice

Published: February 18, 2025

MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.

MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.

Journal: Blood cancer journal

Published: January 19, 2023

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non-Small-Cell Lung Cancer.

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non-Small-Cell Lung Cancer.

Journal: JCO precision oncology

Published: November 10, 2020

Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies.

Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies.

Journal: HemaSphere

Published: August 03, 2020

Schedule-Dependent Synergy Between the Histone Deacetylase Inhibitor Belinostat and the Dihydrofolate Reductase Inhibitor Pralatrexate in T-and B-cell Lymphoma Cells in vitro.

Schedule-Dependent Synergy Between the Histone Deacetylase Inhibitor Belinostat and the Dihydrofolate Reductase Inhibitor Pralatrexate in T-and B-cell Lymphoma Cells in vitro.

Journal: Frontiers in cell and developmental biology

Published: June 29, 2020

High myeloid-derived suppressor cell frequencies in the duodenum are associated with enteropathy associated T-cell lymphoma and its precursor lesions.

High myeloid-derived suppressor cell frequencies in the duodenum are associated with enteropathy associated T-cell lymphoma and its precursor lesions.

Journal: British journal of haematology

Published: June 25, 2016

ALK-negative anaplastic large cell lymphoma is sensitive to bortezomib through Noxa upregulation and release of Bax from Bcl-2.

ALK-negative anaplastic large cell lymphoma is sensitive to bortezomib through Noxa upregulation and release of Bax from Bcl-2.

Journal: Haematologica

Published: May 16, 2015

18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.

18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: January 17, 2015

Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers.

Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers.

Journal: Carcinogenesis

Published: September 20, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026